Targeted Symptom Control in GERD and Dyspepsia: The Role of Alginate and Combination Therapies

  • Live Webinar
  • 2 CPD Points
  • 1 Apr. 2026 at 07:00 PM
In partnership with

Introduction

Acid-related disorders such as GERD and dyspepsia remain highly prevalent and continue to be suboptimally managed in routine clinical practice. In this CME, we review the underlying pathophysiology, highlight current treatment gaps, and examine the role of targeted therapies, including alginate-based formulations and combination antacids, in improving patient outcomes.

Meet your speaker:

Dr Martin Muhoro
Medical Affairs Manager,
Beta Healthcare International Limited

Who Should Enrol

All registered Pharmacists and Pharmaceutical Technologist in Kenya.

Learning Outcomes

The outcomes for this session are:
  • To provide healthcare professionals with practical knowledge on the assessment and symptomatic management of dyspepsia, heartburn, and reflux-related conditions.
  • To strengthen clinician capacity in the effective and rational management of common upper gastrointestinal symptoms.
  • To promote evidence-based, safe, and patient-centered symptom relief in routine clinical practice.  
  • To improve the understanding of dyspepsia and reflux symptoms, treatment selection, mechanism of dual-action therapies, and patient counseling. 

Course Content

The following activities are included within this activity:

Course Lessons

Knowledge Lab Kenya, in partnership with Surgipharm
Surgipharm Nivina Towers, 71 Westlands Roads
Phone number: +254 20 374 9304 / +254 20 374 9306
Terms & Conditions   |   Privacy Policy   |   Cookie policy    |   Disclaimer
Copyright © 2026